Background/Aims: Increases in the renal glucose transporter gene expression are involved in renal tubule-glomerular diseases.Here we investigate the GLUT2 gene expression changes in the kidney of diabetic rats, by using insulin or phlorizin treatment. Methods: Rats were rendered diabetic and studied 20 days later: 4–12 h after one single injection of insulin or phlorizin, and 1–6 days after insulin or phlorizin injection twice a day, comparing with diabetic rats injected with placebo. GLUT2 was investigated by Northern and Western analysis. Results: In 20-day diabetic rats, acute treatment with insulin lowered the plasma glucose and increased the GLUT2 mRNA (∼100%, p < 0.001) without changes in the protein content, while phlorizin lowered the plasma glucose, but changed neither the GLUT2 mRNA nor the protein expression. Twenty-four hours of insulin treatment increased both GLUT2 mRNA (∼100%, p < 0.001) and protein (∼50%, p < 0.01), but no effects of phlorizin were observed. After 6 days, insulin and phlorizin similarly reduced glycemia, with opposite effects upon plasma insulin and urinary glucose, and both treatments decreased GLUT2 mRNA and protein (p < 0.05). Conclusion: In kidney of diabetic rats, an initial and transient upregulation of GLUT2 was induced specifically by insulin only. The 6-day normalization of GLUT2, however, was induced by both insulin and phlorizin treatment, which seems to be related to the plasma glucose lowering.

Keywords:
Diabetes, Insulin treatment, Phlorizin treatment, Glucose transporters, GLUT2
1.
Thorens B: Glucose transporters in the regulation of intestinal, renal, and liver glucose fluxes. Am J Physiol 1996;270:G541–G553.
2.
Dominguez JH, Camp K, Maianu L, Garvey WT: Glucose transporters of rat proximal tubule: differential expression and subcellular distribution. Am J Physiol 1992;262:F807–F812.
3.
Wright EM: Renal Na(+)-glucose cotransporters. Am J Physiol 2001;280:F10–F18.
4.
Marks J, Carvou NJ, Debnam ES, Srai SK, Unwin RJ: Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane. J Physiol 2003;553:137–45.
5.
Schaan BD, Irigoyen MC, Lacchini S, Moreira ED, Schmid H, Machado UF: Sympathetic modulation of the renal glucose transporter GLUT2 in diabetic rats. Auton Neurosci 2005;117:54–61.
6.
Vestri S, Okamoto MM, de Freitas HS, Aparecida Dos Santos R, Nunes MT, Morimatsu M, Heimann JC, Machado UF: Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol 2001;182:105–112.
7.
Adachi T, Yasuda K, Okamoto Y, Shihara N, Oku A, Ueta K, Kitamura K, Saito A, Iwakura I, Yamada Y, Yano H, Seino Y, Tsuda K: T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats. Metabolism 2000;49:990–995.
8.
Chin E, Zamah AM, Landau D, Gronbcek H, Flyvbjerg A, LeRoith D, Bondy CA: Changes in facilitative glucose transporter messenger ribonucleic acid levels in the diabetic rat kidney. Endocrinology 1997;138:1267–1275.
9.
Dominguez JH, Camp K, Maianu L, Feister H, Garvey WT: Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats. Am J Physiol 1994;266:F283–F290.
10.
Kamran M, Peterson RG, Dominguez JH: Overexpression of GLUT2 gene in renal proximal tubules of diabetic Zucker rats. J Am Soc Nephrol 1997;8:943–948.
11.
D’Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H: Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes. Horm Metab Res 2001;33:664–669.
12.
Santer R, Schneppenheim R, Dombrowski A, Gotze H, Steinmann B, Schaub J: Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet 1997;17:324–326.
13.
Berry GT, Baker L, Kaplan FS, Witzleben CL: Diabetes-like renal glomerular disease in Fanconi-Bickel syndrome. Pediatr Nephrol 1995;9:287–291.
14.
Burwinkel B, Sanjad SA, Al-Sabban E, Al-Abbad A, Kilimann MW: A mutation in GLUT2, not in phosphorylase kinase subunits, in hepato-renal glycogenosis with Fanconi syndrome and low phosphorylase kinase activity. Hum Genet 1999;105:240–243.
15.
Yoo TH, Lee SH, Yoon K, Baek H, Chung JH, Lee T, Ihm C, Kim M: Identification of novel mutations in Na-Cl cotransporter gene in a Korean patient with atypical Gitelman’s syndrome. Am J Kidney Dis 2003;42:E11–E16.
16.
Pascual JM, Wang D, Lecumberri B, Yang H, Mao X, Yang R, De Vivo DC: GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol 2004;150:627–633.
17.
Im SS, Kang SY, Kim SY, Kim HI, Kim JW, Kim KS, Ahn YH: Glucose-stimulated upregulation of GLUT2 gene is mediated by sterol response element-binding protein-1c in the hepatocytes. Diabetes 2005;54:1684–1691.
18.
Baroni MG, Cavallo MG, Mark M, Monetini L, Stoehrer B, Pozzilli P: Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM. J Endocrinol 1999;161:59–68.
19.
Briaud I, Rouault C, Reach G, Poitout V: Long-term exposure of isolated rat islets of Langerhans to supraphysiologic glucose concentrations decreases insulin mRNA levels. Metabolism 1999;48:319–323.
20.
Freitas HS, Schaan BD, Seraphim PM, Nunes MT, Machado UF: Acute and short-term insulin-induced molecular adaptations of GLUT2 gene expression in the renal cortex of diabetic rats. Mol Cell Endocrinol 2005;237:49–57.
21.
Paiva L, Binsack R, Machado UF: Chronic acarbose-feeding increases GLUT1 protein without changing intestinal glucose absorption function. Eur J Pharmacol 2002;434:197–204.
22.
Ferrer J, Gomis R, Fernandez Alvarez J, Casamitjana R, Vilardell E: Signals derived from glucose metabolism are required for glucose regulation of pancreatic islet GLUT2 mRNA and protein. Diabetes 1993;42:1273–1280.
23.
Fukumoto H, Seino S, Imura H, Seino Y, Eddy RL, Fukushima Y, Byers MG, Shows TB, Bell GI. Sequence, tissue distribution, and chromosomal localization of mRNA encoding a human glucose transporter-like protein. Proc Natl Acad Sci USA 1988;85:5434–5438.
24.
Rossetti L, Smith D, Shulman GI, Papachristou D, DeFronzo RA: Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 1987;79:1510–1515.
25.
Asano T, Katagiri H, Tsukuda K, Lin JL, Ishihara H, Yazaki Y, Oka Y: Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes 1992;41:22–25.
26.
Neufer PD, Carey JO, Dohm GL: Transcriptional regulation of the gene for glucose transporter GLUT4 in skeletal muscle. Effects of diabetes and fasting. J Biol Chem 1993;268:13824–13829.
27.
Shah GN, Giddings SJ, Mooradian AD: Shortening of poly (A) tail of glucose transporter–one mRNA in experimental diabetes mellitus. Brain Res 1997;754:213–220.
28.
Bolster DR, Jefferson LS, Kimball SR: Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling. Proc Nutr Soc 2004;63:351–356.
29.
Shen W, Scearce LM, Brestelli JE, Sund NJ, Kaestner KH: Foxa3 (hepatocyte nuclear factor 3gamma) is required for the regulation of hepatic GLUT2 expression and the maintenance of glucose homeostasis during a prolonged fast. J Biol Chem 2001;276:42812–42817.
30.
Kim HI, Kim JW, Kim SH, Cha JY, Kim KS, Ahn YH: Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes 2000;49:1517–1524.
31.
Panchapakesan U, Pollock CA, Chen XM: The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells. Am J Physiol 2004;287:F528–F534.
32.
Parrizas M, Maestro MA, Boj SF, Paniagua A, Casamitjana R, Gomis R, Rivera F, Ferrer J: Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol 2001;21:3234–3243.
33.
Waeber G, Thompson N, Nicod P, Bonny C: Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 1996;10:1327–1334.
34.
Cha JY, Kim H, Kim KS, Hur MW, Ahn Y: Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene: cooperative role of hepatocyte nuclear factors 1alpha and 3beta. J Biol Chem 2000;275:18358–18365.
35.
Wu C, Okar DA, Stoeckman AK, Peng LJ, Herrera AH, Herrera JE, Towle HC, Lange AJ: A potential role for fructose-2,6-bisphosphate in the stimulation of hepatic glucokinase gene expression. Endocrinology 2004;145:650–658.
36.
Fleischmann M, Iynedjian PB: Regulation of sterol regulatory-element binding protein 1 gene expression in liver: role of insulin and protein kinase B/cAkt. Biochem J 2000;349:13–17.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.